EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factor Analysis‐Based Quantitative Endotyping Improves Associations With CRS Cross‐Sectional and Longitudinal Outcomes

Brooke N Gleason iD, Zhidi Luo, Aditi Agarwal iD, Siyuan Dong, Regan L Harmon, Junqin Bai iD, Chun-Kang Liao, Julia Huang, David B Conley, Kevin C Welch, Robert C Kern, Stephanie S Smith iD und 5 weitere

International Forum of Allergy & Rhinology · 2026

DOI: 10.1002/alr.70027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2026. Verfasst von Brooke N Gleason und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NIDCD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disease characterized by persistent sinonasal inflammation. There is increasing interest in endotype‐based classification, which categorizes CRS based on underlying inflammatory pathways. We applied factor analysis to facilitate continuous endotype assignment to CRS patients and assess cross‐sectional and longitudinal CRS outcomes.

Methods

We prospectively enrolled 203 patients (52 controls, 88 CRSsNP, and 63 CRSwNP) undergoing endoscopic nasal or sinus surgery (ESS). Middle meatal mucus biomarkers were analyzed pre‐ESS (V0) and 6–12 months post‐ESS (V1). Factor analysis was performed to identify latent factors. Factor scores were generated, and statistical analyses were conducted to assess correlations with radiographic (Lund–Mackay [LM]) and patient‐reported (SNOT‐22, CRS‐PRO) outcomes measured at V0, V1, and V2 (1.5–5 years post‐ESS).

Results

Four factors were identified: Type 1 (T1), Type 2 (T2), Type 3 (T3), and macrophage‐associated (M). CRSwNP patients had higher T2 and M factor scores than CRSsNP and controls. T2, T3, and M factor scores demonstrated stronger or equivalent associations with radiographic and patient‐reported outcomes compared to individual biomarkers. Following ESS, median T2 and M factor scores significantly declined, while T1 and T3 remained stable. V0 T1 and T2 were weakly associated with long‐term (V2) radiographic and symptom scores. V1 factor scores were more consistently predictive of long‐term (V2) outcomes, with T2, T3, and M demonstrating modest correlations with radiographic severity and CRS‐PRO.

Conclusions

Factor analysis identifies distinct, quantifiable patterns of inflammation in CRS, offering improved associations with cross‐sectional and longitudinal outcomes compared to individual biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SinusitisRhinitisHumansFemaleMaleMiddle AgedCross-Sectional StudiesLongitudinal StudiesAdultChronic DiseaseBiomarkersFactor Analysis, StatisticalAgedProspective StudiesEndoscopy

Stichwörter der Autor:innen

biomarkerchronic rhinosinusitisdisease severityendoscopic sinus surgeryendotypepatient reported outcomes

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Psychiatry and Behavioral Science, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Preventive Medicine (Biostatistics and Informatics), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Brooke N Gleason, Aditi Agarwal, Junqin Bai, Stephanie S Smith, Anju T Peters, Whitney S Stevens, Bruce K Tan

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NIDCD NIH HHS
  • National Institutes of Health

Zitieren

APA

Gleason, B. N., Luo, Z., Agarwal, A., Dong, S., Harmon, R. L., Bai, J., Liao, C. K., Huang, J., Conley, D. B., Welch, K. C., Kern, R. C., Smith, S. S., Peters, A. T., Stevens, W. S., Kato, A., Muhammad, L. N., & Tan, B. K. (2026). Factor Analysis‐Based Quantitative Endotyping Improves Associations With CRS Cross‐Sectional and Longitudinal Outcomes. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.70027

Vancouver

Gleason BN, Luo Z, Agarwal A, Dong S, Harmon RL, Bai J, et al. Factor Analysis‐Based Quantitative Endotyping Improves Associations With CRS Cross‐Sectional and Longitudinal Outcomes. International Forum of Allergy & Rhinology. 2026. doi:10.1002/alr.70027

BibTeX
@article{Gleason2026,
  author = {Gleason, Brooke N and Luo, Zhidi and Agarwal, Aditi and Dong, Siyuan and Harmon, Regan L and Bai, Junqin and Liao, Chun-Kang and Huang, Julia and Conley, David B and Welch, Kevin C and Kern, Robert C and Smith, Stephanie S and Peters, Anju T and Stevens, Whitney S and Kato, Atsushi and Muhammad, Lutfiyya N and Tan, Bruce K},
  title = {Factor Analysis‐Based Quantitative Endotyping Improves Associations With CRS Cross‐Sectional and Longitudinal Outcomes},
  journal = {International Forum of Allergy & Rhinology},
  year = {2026},
  doi = {10.1002/alr.70027}
}
Kostenlos starten →